As we stand on the brink of the personalized medicine era, breakthroughs in areas like genomics are opening up a whole new range of privacy, reliability and security issues. Embedding security and privacy within strategy empowers Life Sciences companies.
This month marks the 16th anniversary of the first full publication of the human genome. Far from being old news, the potential of genomics continues to grow. In what’s already a period of transformation for Life Sciences companies, how can they drive value from genomics, and what are the pitfalls to be avoided?
The French data protection authority imposed a fine of 50 million euros against Google for violating the EU’s General Data Protection Regulation (GDPR) principles. What does this decision mean for your business, for your website and for your processes?